Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Eli Lilly & Co | 5.71% | $828.69K | $1.00T | 41.67% | 76 Outperform | |
| Cardinal Health | 5.34% | $774.66K | $49.77B | 71.93% | 65 Neutral | |
| Waste Management | 4.85% | $703.58K | $87.27B | -3.47% | 68 Neutral | |
| McKesson | 4.68% | $678.97K | $106.89B | 38.97% | 72 Outperform | |
| UnitedHealth | 4.57% | $662.98K | $289.84B | -45.85% | 67 Neutral | |
| Johnson & Johnson | 4.41% | $639.84K | $491.26B | 31.40% | 78 Outperform | |
| Microsoft | 4.37% | $634.53K | $3.51T | 13.22% | 73 Outperform | |
| Coca-Cola | 4.30% | $624.74K | $313.80B | 14.13% | 78 Outperform | |
| Chubb | 4.26% | $618.06K | $117.39B | 4.59% | 80 Outperform | |
| Rentokil Initial | 4.26% | $617.60K | $13.34B | 3.77% | 66 Neutral |